معرفی
Mark E. Pennesi is a Professor at Oregon Health & Science University's Casey Eye Institute, specializing in inherited retinal diseases and gene therapy. His research bridges translational medicine with clinical applications, focusing on retinal dystrophies and genetic disorders.
- Education: BS in Biomedical Engineering (University of Pennsylvania, 1997), PhD in Neuroscience (Baylor College of Medicine, 2003), MD (Baylor College of Medicine, 2004)
Dr. Pennesi's work explores novel treatments for conditions like retinitis pigmentosa and choroideremia, including subretinal gene therapy (HORIZON trial) and metabolic disorder research in LCHADD. His publications highlight advancements in retinal imaging, biomarker identification, and therapeutic monitoring.
Recent articles address electrophysiology, animal models, and disease staging systems, emphasizing interdisciplinary approaches combining genetics, metabolomics, and clinical trials.
- Scientific Awards: ARVO/Alcon Early Clinician Scientist Award (2011), Alcon Young Investigator Award (2014), Casey Eye Institute Resident Teaching Award
Dr. Pennesi has secured career development funding from Research to Prevent Blindness and the Foundation Fighting Blindness. He collaborates with institutions globally on multicenter studies and contributes to patient-reported outcome validation.
